Access to a Cure: Ensuring Equitable Access to Cell and Gene Therapies for Children with Sickle Cell Disease
ASGCT Partners with Children’s Hospital Association on Sickle Cell Disease Access
Christina Mayer | August 04, 2025
Achieving equitable access to gene therapies requires coordinated action across clinical care delivery, healthcare administration, and payment policy. By tackling the issues raised at the briefing, we can help ensure the next generation of SCD therapies reach patients, wherever they are.
Policy & Advocacy
Read Full Story